In brief

  • Novo Nordisk changes its name to 'Novo' and launches a new culture model.

  • VD Mike Doustdar links changes to losing ground against Eli Lilly.

  • Novo’s stock has fallen by about 15% so far this year despite the restructuring.

Read the original story Novo Nordisk changes its name to ‘Novo’: Shares fall as the company directs GLP-1 toward consumers by Darryn Pollock on se.beincrypto.com